Home » Celsis Expands into Mass Spec and Ion Chromatography
Celsis Expands into Mass Spec and Ion Chromatography
Chicago, Ill. – Celsis Analytical Services, a division of Celsis International, announced the company has expanded the analytical chemistry capabilities of its accredited cGMP labs to include Mass Spectrometry (LC-MS/MS) and Ion Chromatography, making it easier to analyze complex materials and compounds.
“With the availability of mass spectrometry and ion chromatography, Celsis has increased its commitment to provide cost-effective, outsourced CGMP-certified laboratory services,” said Marc Caira, director of business development, Celsis Analytical Services. “Now, suppliers and manufacturers in a wide variety of industries – including pharmaceutical, biotechnology and consumer goods – can address their specialized testing needs, while avoiding costly investments in additional lab space, personnel and equipment.”
Referenced in several chapters of the US Pharmacopeia (USP), LC-MS/MS enables analysts to separate, quantify and identify elements in complex mixtures. The LC-MS/MS testing method works by using HPLC to first separate the compounds. The mass spectrometer (MS) filters the separation in order to detect and identify components. A second MS may be used to further refine identifications. Celsis has both the Sciex API 5000 tandem (triple) Quadrupole and the Micromass Quattro Ultima mass spectrometers. In addition to USP testing, the mass spectrometry equipment can be used for raw material characterization, impurity identification, quality control programs and more.
Ion Chromatography Capabilities
The Dionex ICS-3000 ion chromatographic (IC) system has conductivity, amperometry and UV detectors. The system not only determines inorganic action, cations and organic acids but also uses amperometric detection for accurate analysis of traditionally difficult-to-analyze materials. These powerful IC techniques fill the void between liquid chromatography and gas chromatography analysis. Additional methods and benefits include: low level ion analysis with suppressed ion chromatography; conductivity detection for compounds such as sulphate, phosphate and fluoride; and integrated pulsed amperometry that overcomes problematic analysis of non-soluble products of an oxidation or reduction.
Visit www.celsis.com for more information.
Syrian Pharma Production Nearly Halted by WarFrom AFP
A shortage of foreign currency has brought production to a near halt in Syria
Camfil APC Opens Manufacturing Plant in the UKFrom Camfil
Camfil announced the grand opening of its new 40,000-sq.-ft. facility
Actavis Acquiring Warner Chilcott for $8.5BFrom AP
Actavis to buy Warner Chilcott in an all-stock transaction
Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics
NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration
Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com
Agreement creates unique strategic collaboration for development and clinical trial execution
$15 Billion Myland Offer Rejected By ActavisFrom Bloomberg.com
Actavis has rejected drugmaker Mylan Inc's cash-and-stock offer for $15 billion. They have decided to continue talks to take over Warner Chilcott Plc instead, sources have said.
Rapid Micro Biosystems Offers Workshops at New European Headquarters in MunichFrom Rapid Micro Biosystems
Company hosts hands-on demonstrations of its Growth Direct System
Amgen, Zhejiang Beta Pharma Form Joint VentureFrom FOX Business
Amgen will form a joint venture with Chinese pharma firm to bring its colon cancer drug Vectibix to the Chinese market
Academic Tech Transfer Collaboration Required for Pharma R&D ModelFrom IT News Online
Pharma R&D Model Needs Academic Tech Transfer Collaboration for the Future of Drug Innovation Says New Report
CEM Wins Solid-Phase Peptide Synthesis Patent DisputeFrom CEM
CEM's European Patent covering microwave assisted solid phase peptide synthesis has been upheld in an oral proceeding
- All news »